GE Healthcare has announced a new collaboration with National Cancer Centre Singapore (NCCS), which focuses on how artificial intelligence (AI) driven research can be used to improve cancer care.

The collaboration is the first of its kind for GE Healthcare in the Asia-Pacific (APAC) region and aims to spur the potential for more tailored treatment options for specific cancer types and offer the potential to evaluate clinically significant information along the patient journey for a provider's efficient decision making, leveraging on AI and text processing.

The agreement between GE Healthcare and NCCS will see the two organizations collaborate on new AI-powered solutions for data analytics and clinical workflows that support care for cancer patients in this part of the world-combining GE Healthcare's imaging and monitoring expertise with NCCS's deep expertise in research and development, testing and consultation. 

The collaboration is the latest in a series of alliances which GE Healthcare has established to support integrated healthcare systems at the local level through improved access to advanced AI technologies and innovations. These include collaborations with SOPHiA GENETICS in the United States and the University of Cambridge and Optellum in the United Kingdom.